Live: ACHEMA Opening Day Report - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Live: ACHEMA Opening Day Report

In 2009 there were 3767 exhibitors and more than 173000 visitors to ACHEMA in Frankfurt. The 2012 event looks to be even bigger. The hot topics for this year are energy and resources, while congress topics will address process engineering, pharmaceutical production and biotechnology. On the opening day, I saw a variety of new technologies for the pharma industry.

Lock showcased a gravity fall metal detection system that promises a greater product integrity for API manufacturers. They also have a bottlecheck system that incorporates an 'OPTIX' detector that inspects bottles of tablets and capsules at the end of the packaging line.

Thomas Homann of GEA showed me a separator for the recovery of vaccines and pharmaceutical proteins in lab scale and pilot plant applications. It operates at 20000G, which is unique worldwide. There are three bowl sizes, 15-30 L/h up to 150-300L/h. Of course, it is a sterile system that meets GMP requirements.

Merck Millipore have the only complete single-use process train that promises scalable, industry standard separation and purification technologies. The highest level of flexibility for multi-product, multi-scale facilities with modular units for scaling up, down and across unit operations.

More news to come soon!


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here